St John's DermAcademy Podcast

Episode 17: Part 2 - Eczema Therapeutics

Fri, 05 Jul 2024 13:00:00 +0100

In this episode our host Dr Sarah Drummond speaks with Professor Catherine Smith and Dr Andrew Pink about eczema therapeutics:

• The use of JAK inhibitors licensed for use in managing eczema including their mechanism of action, monitoring requirements and potential side effects.
• Newer agents currently under investigation.
• The BEACON trial

Recorded: 19 March 2024

For more information, visit: www.stjohnsdermacademy.com/podcasts

Disclaimer: The information on our podcasts is based on the latest evidence and expert opinion at the time of recording. The information is for general purposes only and we cannot offer advice for specific patients. Equally, this information is geared towards healthcare professionals. Any member of the public or patients listening should not use this as advice to treat their own condition or others and should consult their own physician for any medical needs they may have.

Episode 16: Part 1 - Eczema Therapeutics

Fri, 05 Jul 2024 13:00:00 +0100

In this episode our host Dr Sarah Drummond speaks with Professor Catherine Smith and Dr Andrew Pink about eczema therapeutics:

• Where conventional systemic agents fit within the evolving landscape of eczema therapeutics.
• The biologic agents licensed for use in eczema including their mechanism of action, monitoring requirements and potential side effects.

Recorded: 19 March 2024

For more information, visit: www.stjohnsdermacademy.com/podcasts

Disclaimer: The information on our podcasts is based on the latest evidence and expert opinion at the time of recording. The information is for general purposes only and we cannot offer advice for specific patients. Equally, this information is geared towards healthcare professionals. Any member of the public or patients listening should not use this as advice to treat their own condition or others and should consult their own physician for any medical needs they may have.

Episode 15: Part 2: Immunobullous disorders - Pemphigus vulgaris

Fri, 07 Jun 2024 13:00:00 +0100

In this episode our host Dr Sarah Drummond speaks with Dr Thomas Tull about pemphigus vulgaris:

• The clinical features of pemphigus vulgaris and other variants of pemphigus.
• The step-wise management of pemphigus vulgaris including an approach to managing severe disease and the use of rituximab and intravenous immunoglobulin .

Resources and further reading:
• British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris, 2017 (https://onlinelibrary.wiley.com/doi/full/10.1111/bjd.15930)
• European guidelines for the management of pemphigus vulgaris and foliaceous initiated by the European Academy of Dermatology and Venereology, 2020 (https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.16752)
• Rituximab and Covid-19 Risk – a single-centre cohort study (https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(23)00004-8/fulltext)
• Phase 2 Study of efficacy and safety of Rilzabrutinib for patients with pemphigus vulgaris (https://pubmed.ncbi.nlm.nih.gov/35686647/)
• Phase 2 Study of the use of Efgartigimod for patients with pemphigus vulgaris and foliaceous (https://pubmed.ncbi.nlm.nih.gov/34608631/)

Disclosure: Dr. Tull provides consultancy services for Argenx who market Efgartigimod, which has been referenced in Part 1 and 2 of this series.

Recorded date: 26 January 2024

Episode 14: Part 1: Immunobullous disorder - Bullous pemphigoid

Fri, 07 Jun 2024 13:00:00 +0100

In this episode our host Dr Sarah Drummond speaks with Dr Thomas Tull about bullous pemphigoid:
• The clinical features and risk factors for developing bullous pemphigoid
• How to differentiate bullous pemphigoid from other subepidermal blistering disorders
• Management of bullous pemphigoid including:
o Preferred first and second line agents
o How and when to reduce treatment
o What to do in severe and refractory cases

Resources and further reading:
• European guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology, 2022 (updated) (https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.18220)
• British Association of Dermatologists’ guidelines for the management of bullous pemphigoid, 2012 (https://onlinelibrary.wiley.com/doi/full/10.1111/bjd.12072)

Disclosure:
Dr. Tull provides consultancy services for Argenx who market Efgartigimod, which has been referenced in Part 1 and 2 of this series.

Recorded date: 26 January 2024

Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.

Episode 13: Vulval skin conditions - Part 2: Management

Mon, 06 Feb 2023 01:00:00 +0000

In this episode our host Dr Justin Bui speaks to Dr Fiona Lewis about vulval skin conditions.

In this episode we discuss…

· Management of lichen sclerosus, including what to do when topical steroids are not effective

· Management of vulval eczema and psoriasis

· When to refer to a tertiary service

Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.

Episode 12: Vulval skin conditions - Part 1: History and Examination

Mon, 06 Feb 2023 00:00:00 +0000

In this episode our host Dr Justin Bui speaks to Dr Fiona Lewis about vulval skin conditions.

In this episode we discuss…

· Common presentations of vulval skin conditions

· Diagnostic clues in the history

· Clinical examination

· When to consider further investigations including a biopsy

Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.

Episode 11: Vitiligo - Part 2: Management of vitiligo

Mon, 21 Nov 2022 10:00:00 +0000

In this episode our host Dr Justin Bui speaks to Dr John Ferguson about vitiligo.

We discuss…

Treatment approach for vitiligo
Other treatments on the horizon
Vitiligo and skin cancer surveillance
Sunscreens

Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.

Episode 10: Vitiligo - Part 1: An introduction to vitiligo

Mon, 21 Nov 2022 09:00:00 +0000

In this episode our host Dr Justin Bui speaks to Dr John Ferguson about vitiligo.

We discuss…

What is vitiligo?
The changing perception of vitiligo as a skin disease
An approach to examining patients with vitiligo
Other conditions associated with vitiligo

Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.

Episode 9: Paediatric Psychodermatology - Part 2: Management of children and young people with psychodermatology problems

Thu, 18 Nov 2021 17:00:00 +0000

In this episode our host Dr Alison Sears speaks to Dr Susannah Baron and Dr Rukshana Ali about paediatric psychodermatology.

We discuss…

· Compulsive hair pulling (trichotillomania)

· Medically unexplained skin signs

· Psychological tools/exercises

· Practical top tips

Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.

Episode 8: Paediatric Psychodermatology - Part 1: An introduction and practical approach

Wed, 22 Sep 2021 22:00:00 +0100

In this episode our host Dr Alison Sears speaks to Dr Susannah Baron and Dr Rukshana Ali about paediatric psychodermatology.

We discuss…

· What is psychodermatology?

· Ways of establishing rapport and communicating effectively with children/young people and their families.

· History taking in paediatric psychodermatology

· The importance of communication with parents around acceptance of a child as they are, if they have a skin condition which has a visible difference.

Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.

Episode 7: Acne scarring - Part 2: Treating atrophic acne scars

Wed, 26 May 2021 22:00:00 +0100

In this episode we discuss…

The indications, benefits and pitfalls of the following treatments for acne scaring:

· Surgical procedures including subcision and punch excision

· Procedures such as microneedling, chemical peels and soft tissue augmentation

· Ablative and non-ablative lasers

Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.

Episode 6: Acne scarring - Part 1: Introduction to atrophic acne scarring

Wed, 26 May 2021 22:00:00 +0100

In this episode we discuss…

· What causes acne scarring

· When to treat

· How to assess patients

· Different types of atrophic acne scars

Visit our website https://www.stjohnsdermacademy.com/podcasts for show notes and references.

Episode 5: Cutaneous Sarcoidosis - Part 2: Screening for systemic involvement and treatment

Tue, 04 Aug 2020 00:00:00 +0100

In this episode we discuss:

· Screening questions and investigations to assess for the presence of systemic disease

· Treatment of cutaneous sarcoidosis

· Assessing disease response and monitoring

Episode 4: Cutaneous Sarcoidosis - Part 1: Definition, epidemiology and clinical features characterising cutaneous sarcoidosis

Tue, 04 Aug 2020 00:00:00 +0100

In this episode we discuss:

· Definition, aetiology and epidemiology of cutaneous sarcoidosis

· Clinical features that characterise cutaneous sarcoidosis

· Diagnosis of cutaneous sarcoidosis

Episode 3: Occupational dermatoses during the COVID-19 pandemic

Tue, 09 Jun 2020 22:00:00 +0100

In this episode our host Dr Ally Paolino speaks to Dr Felicity Ferguson about the common types of skin problems in health care workers as a result of heightened personal protective equipment and strategies to prevent and treat these occupational dermatoses.

Episode 2: Cutaneous manifestations of COVID-19

Tue, 09 Jun 2020 19:00:00 +0100

In this episode Dr Rachael Morris-Jones talks to our host, Dr Ally Paolino about SARS-CoV-2, the typical symptoms and phases of the viral illness, the cutaneous manifestations and their association with disease severity.

Episode 1: How I diagnose and treat facial hyperpigmentation with Dr Emma Craythorne

Tue, 19 May 2020 15:00:00 +0100

In this episode Dr Emma Craythorne talks to our host, Dr Ally Paolino about facial hyperpigmentation, the common causes, treating melasma (including topical, laser and tranexamic acid treatments) and post inflammatory hyperpigmentation.